Best Liver Cancer Stage 4 Doctors Abroad for Australian Patients

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Associate Professor Eda Tanrikulu ranked 3rd in Turkey's prestigious national medical specialty exam and now leads advanced oncology cases at Anadolu Medical Center.

• Specialises in tailored chemotherapy and biological therapies for metastatic liver disease
• Practices at an institution affiliated with the world-renowned Johns Hopkins Medicine
• Maintains international standards through memberships in ASCO and ESMO
• Completed specialist training in metastatic colorectal cancer at the University of Oxford
• Managed complex oncology units at major Turkish training and research hospitals

Dr. Abdulcabbar Kartal is a colorectal and general surgeon at Anadolu Medical Center. He specializes in HIPEC and bariatric surgery. He has performed over 500 bariatric procedures. Dr. Kartal holds certification from the European Society of Coloproctology (FEBS-C). He works at a clinic affiliated with Johns Hopkins Medicine.

• Completed over 650 surgical operations across major hospitals in Turkey.
• Certified by the Turkish Surgical Association for his surgical qualifications.
• Uses laser techniques for hemorrhoidal diseases and interventional endoscopic procedures.
• Member of the Turkish Association of Endoscopic Laparoscopic Surgery.

Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.

• President of the Turkish Society for Radiation Oncology.
• Chair of the ESTRO National Societies Committee.
• Recipient of the ASCO International Development and Education Award.
• Author of over 70 international peer-reviewed publications.

Dr. Murat Dokdok is a specialized interventional radiologist at Anadolu Medical Center. He completed an interventional neuroradiology fellowship at the University Hospital of Zurich. Dr. Dokdok also held a fellowship at Harvard Medical School. He focuses on neurological therapy and imaging for conditions like cerebral aneurysms and liver cancer. Dr. Dokdok works at Anadolu, a facility affiliated with Johns Hopkins Medicine.

• Holds over 100 national and international scientific publications and presentations.
• Certified by the European Society of Neuroradiology.
• Member of the Cardiovascular and Interventional Radiology Society of Europe.
• Performs radiofrequency ablation and chemoembolization for oncology patients.

Dr. Ayshe Okumush is a radiation oncologist at Private NeoLife Medical Center. She earned her MD from Karadeniz Technical University in 2003. She completed a residency in radiation oncology at Sisli Etfal Training and Research Hospital from 2006 to 2011.

She served as a specialist at Diyarbakir Uckuyular Training and Research Hospital from 2011 to 2013 and at Sisli Etfal from 2013 to 2016. She then worked at Yeni Yuzyil University Private Gaziosmanpasa Hospital from 2016 to 2026. She joined NeoLife in 2026.

Memberships: Turkish Society for Radiation Oncology (TROD) and the European Society for Radiotherapy and Oncology (ESTRO). Clinical focus: SRS, SRT, SBRT; VMAT, IMRT; radiotherapy for head and neck, lung, and brain tumors; SGRT, TBI, and 3D brachytherapy.

Professor Sezer Sağlam is a senior specialist in gastrointestinal oncology at Gayrettepe Florence Nightingale Hospital. He focuses on advanced cancer cases within the digestive system.

• Specialises in gastrointestinal oncology, focusing on tumours of the liver and digestive tract
• Professor at the Istanbul University Oncology Institute, a leading Turkish research centre
• Member of the European Neuroendocrine Tumour Society (ENET) for specialised tumour care
• Active member of the American Society of Clinical Oncology (ASCO)
• Fellowship-trained in medical oncology at the prestigious Istanbul University

Dr. Sefik Igdem is a radiation oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating head, neck, and prostate cancers. He currently serves as a Professor at Demiroğlu Bilim University. Dr. Igdem uses Truebeam STx and Halcyon systems for accurate radiotherapy.

• Specializes in conformal treatments for complex tumor cases.
• Treats various conditions including lung, breast, and brain tumors.
• Practices at a JCI-accredited hospital that serves 200,000 patients annually.
• Completed his radiation oncology training at the Istanbul University Cerrahpaşa Faculty.

Dr. Mehmet Salih Iyikesici is a medical oncologist. His work focuses on metabolically supported chemotherapy (MSCT), ketogenic diet–supported cancer care, hyperthermia, hyperbaric oxygen therapy, and insulin potentiation therapy. He emphasizes care for breast, pancreatic, and gastric cancers.

He is a Medical Oncology Specialist at Neolife Medical Center (2026–present). He previously served at Private Bahçelievler Medical Park (2013–2026), Medicana Beylikdüzü (2010–2013), Silivri Anadolu (2009–2010), Diyarbakır Training and Research (2008–2009), and Bursa Çekirge State (2006–2008). Earlier, he worked as an Internal Medicine Specialist (1997–2003). He was an Assistant Professor at Altınbaş University (2014–2026).

Training: Medical Oncology subspecialty, Marmara University (2003–2006). Internal Medicine, Istanbul Haydarpaşa Numune (1992–1996). Medicine, Uludağ University (1985–1990). Member, Medical Oncology Association (since 2004). His recent research (2019–2020) covers gastric, breast, pancreatic, and lung cancers. Topics include long‑term survival in metastatic pancreatic cancer and feasibility in metastatic non‑small cell lung cancer (NSCLC).